S303: EFFECT OF PEGCETACOPLAN ON QUALITY OF LIFE IN COMPLEMENT-INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE PHASE 3 PRINCE STUDY
D. Gomez-Almaguer,
R. Wong,
T. Dumagay,
M. Al-Adhami,
J. Savage,
Z. Hakimi,
A. Bogdanovic
Affiliations
D. Gomez-Almaguer
1 Hematology Service, Hospital Universitario “Dr José Eleuterio González,” Universidad Autónoma de Nuevo León, Monterrey, Mexico
R. Wong
2 Sir Y.K. Pao Centre for Cancer & Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
T. Dumagay
3 Department of Cellular Therapeutics, Makati Medical Centre, Makati, Philippines
M. Al-Adhami
4 Apellis Pharmaceuticals, Inc., Waltham, United States of America
J. Savage
4 Apellis Pharmaceuticals, Inc., Waltham, United States of America
Z. Hakimi
5 Swedish Orphan Biovitrum AB, Stockholm, Sweden
A. Bogdanovic
6 Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia